Long term treatment of moderate hypertension with penbutolol (Hoe 893d) III. Effects on glucose tolerance and insulin production

1976 ◽  
Vol 10 (3-4) ◽  
pp. 157-162 ◽  
Author(s):  
B. -G. Hansson ◽  
B. H�kfelt
Keyword(s):  
Glucose Tolerance ◽  
Moderate Hypertension ◽  
Term Treatment ◽  
Insulin Production ◽  
Long Term Treatment

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol

1977 ◽  
Vol 11 (4) ◽  
pp. 247-254 ◽  
Author(s):  
B. -G. Hansson ◽  
J. -F. Dymling ◽  
P. Manhem ◽  
B. H�kfelt
Keyword(s):  
Moderate Hypertension ◽  
Blocking Agent ◽  
Term Treatment ◽  
Receptor Blocking ◽  
Long Term Treatment

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol

1977 ◽  
Vol 11 (4) ◽  
pp. 239-245 ◽  
Author(s):  
B. -G. Hansson ◽  
J. -F. Dymling ◽  
H. Hedeland ◽  
U. L. Hulth�n
Keyword(s):  
Moderate Hypertension ◽  
Blocking Agent ◽  
Term Treatment ◽  
Receptor Blocking ◽  
Long Term Treatment

Short- and long-term treatment of mild to moderate hypertension with verapamil

1986 ◽  
Vol 57 (7) ◽  
pp. D83-D86 ◽  
Author(s):  
Pierre Wicker ◽  
Raymond Roudaut ◽  
Philippe Gosse ◽  
Modeste Dallocchio
Keyword(s):  
Moderate Hypertension ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Short And Long Term

scholarly journals Glucose tolerance during long term treatment with a somatostatin analogue

BMJ ◽  
1987 ◽  
Vol 294 (6565) ◽  
pp. 176-177
Author(s):  
K C McHardy ◽  
D W M Pearson
Keyword(s):  
Glucose Tolerance ◽  
Term Treatment ◽  
Somatostatin Analogue ◽  
Long Term Treatment

The Effect of Practolol (‘Eraldin’) in the Long-Term Treatment of Severe and Moderate Hypertension

1973 ◽  
Vol 45 (s1) ◽  
pp. 167s-170s ◽  
Author(s):  
R. M. Fulton ◽  
E. Hilda Fulton ◽  
K. G. Green
Keyword(s):  
Moderate Hypertension ◽  
Severe Hypertension ◽  
Term Treatment ◽  
Blood Levels ◽  
Safety Factors ◽  
First Choice ◽  
Long Term Treatment ◽  
Additional Safety

1. The results of a clinical trial of practolol in sixty-one patients with moderate and severe hypertension are presented. Alone or with a diuretic the drug was highly effective in thirty patients, and in a further eight who developed side effects. Effectiveness was not directly related to dosage or blood levels of drug, or to the severity of the hypertension. 2. Nine non-responders to practolol were found to respond to propranolol which is probably a more widely effective antihypertensive agent. Nevertheless, the additional safety factors of practolol and twice daily dosing make it first choice for many patients. We have been impressed by the ability of both β-blocking drugs to control blood pressure without impairing the quality of every-day life.

Sign in / Sign up

Export Citation Format

Share Document